Article
Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients.
Scientific reports - 6 Jul 2016
Kato Kikuya, Uchida Junji, Kukita Yoji, Kumagai Toru, Nishino Kazumi, Inoue Takako, Kimura Madoka, Oba Shigeyuki, Imamura Fumio
Abstract excerpt
Monitoring of disease/therapeutic conditions is an important application of circulating tumor DNA (ctDNA). We devised numerical indices, based on ctDNA dynamics, for therapeutic response and disease progression. 52 lung cancer patients subjected to the EGFR-TKI treatment were prospectively collected, and ctDNA levels represented by the activating and T790M mutations were measured using deep sequencing. Typically,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
